Dana Seidlová-Wuttke
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Dana Seidlová-Wuttke has a total of 32 co-authors. Here are the top co-authors by number of shared publications:
- Wolfgang Wuttke
Hormone and Obesity Center Goettingen, Göttingen, Germany
4 shared publications - Hubertus Jarry
Georg-August-University, Göttingen, Germany
2 shared publications - Volker Christoffel
CSC - Christoffel Scientific Consulting, Bergstr. 11, 92369 Sengenthal, Germany
2 shared publications Wolfgang Wuttke
Department of Endocrinology, University Medical Center Göttingen, Georg-August-Universität, Robert-Koch-Straße, 40, 37099 Göttingen, Germany
2 shared publicationsAlexander Schultens
1 shared publicationBarbara Spengler
1 shared publication
Latest Publications
- 1 December 2010
- Published by Georg Thieme Verlag KG in Zeitschrift für Phytotherapie
- Vol. 31 (06) , 294-298
Der Stellenwert des Mönchspfeffers (Vitex agnus-castus) in der gynäkologischen Endokrinologie
Extrakte aus der getrockneten Frucht des Mönchspfeffers (Vitex agnus-castus = VAC) enthalten dopaminerge Substanzen, die die hypophysäre Prolaktinsekretion hemmen. Die prämenstruelle Mastodynie, aber auch – wie in jüngster Zeit wissenschaftlich belegt – die fibrozystische Mastopathie werden durch Prolaktin in ihrer Entstehung gefördert, sodass viele Patientinnen, die unter Stresssituationen oder Tiefschlafbedingungen vermehrt Prolaktin ausschütten, diese Mammasymptomatik entwickeln, die durch VAC günstig beeinflusst wird. Diese sogenannte latente Hyperprolaktinämie kann auch zur Corpus-luteum-Insuffizienz und damit zur Sterilität führen. In diesen Fällen kann die Agnus-castus-Therapie fertilitätsfördernd wirken. The status of chaste tree (Vitex agnus-castus) in gynaecological endocrinology Extracts of the dried fruits of the chaste tree (Vitex agnus-castus, VAC) contain dopaminergic compounds which are inhibitory to pituitary prolactin release. The development of premenstrual mastalgia as well as of fibrocystic breast changes involves an action of prolactin. Hence, treatment with VAC is helpful to prevent these mammary gland symptoms. Prolactin is also involved in the function of the corpus luteum and patients with a latent hyperprolactinemia often suffer from a corpus luteum insufficiency where treatment with VAC extracts may also be helpful to improve fertility.
- 1 December 2010
- Published by Georg Thieme Verlag KG in Zeitschrift für Phytotherapie
- Vol. 31 (06) , 294-298
Der Stellenwert des Mönchspfeffers (Vitex agnus-castus) in der gynäkologischen Endokrinologie
Extrakte aus der getrockneten Frucht des Mönchspfeffers (Vitex agnus-castus = VAC) enthalten dopaminerge Substanzen, die die hypophysäre Prolaktinsekretion hemmen. Die prämenstruelle Mastodynie, aber auch – wie in jüngster Zeit wissenschaftlich belegt – die fibrozystische Mastopathie werden durch Prolaktin in ihrer Entstehung gefördert, sodass viele Patientinnen, die unter Stresssituationen oder Tiefschlafbedingungen vermehrt Prolaktin ausschütten, diese Mammasymptomatik entwickeln, die durch VAC günstig beeinflusst wird. Diese sogenannte latente Hyperprolaktinämie kann auch zur Corpus-luteum-Insuffizienz und damit zur Sterilität führen. In diesen Fällen kann die Agnus-castus-Therapie fertilitätsfördernd wirken. The status of chaste tree (Vitex agnus-castus) in gynaecological endocrinology Extracts of the dried fruits of the chaste tree (Vitex agnus-castus, VAC) contain dopaminergic compounds which are inhibitory to pituitary prolactin release. The development of premenstrual mastalgia as well as of fibrocystic breast changes involves an action of prolactin. Hence, treatment with VAC is helpful to prevent these mammary gland symptoms. Prolactin is also involved in the function of the corpus luteum and patients with a latent hyperprolactinemia often suffer from a corpus luteum insufficiency where treatment with VAC extracts may also be helpful to improve fertility.
- 1 September 2010
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
- Vol. 95 (9) , 4476
Contribution of a Membrane Estrogen Receptor to the Estrogenic Regulation of Body Temperature and Energy Homeostasis
- 1 September 2010
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
- Vol. 95 (9) , 4476
Contribution of a Membrane Estrogen Receptor to the Estrogenic Regulation of Body Temperature and Energy Homeostasis
- 8 August 2010
- Published by Elsevier in Phytomedicine
- Vol. 17 (11) , 890-894
The Cimicifuga racemosa special extract BNO 1055 prevents hot flashes in ovariectomized rats
- 8 August 2010
- Published by Elsevier in Phytomedicine
- Vol. 17 (11) , 890-894
The Cimicifuga racemosa special extract BNO 1055 prevents hot flashes in ovariectomized rats
- 17 September 2009
- Published by Georg Thieme Verlag KG in Planta Medica
- Vol. 76 (03) , 235-240
Changes in the Histomorphometric and Biomechanical Properties of the Proximal Femur of Ovariectomized Rat after Treatment with the Phytoestrogens Genistein and Equol
The isoflavonoids found in soy have attracted great interest as dietary phytoestrogens that might be effective for postmenopausal hormone replacement therapy. Special attention has been devoted to the hormonal effects of various isoflavonoids, like genistein (GEN) and daidzein's (DAID) potent metabolite, equol (EQ). Here we aimed to investigate the short-term effects of genistein and equol on the proximal femur of ovariectomized (OVX) rats. Forty-eight, 3-month-old female Sprague-Dawley rats were ovarectomized; after eight weeks the bilateral osteotomy and osteosynthesis (OS) of their tibiae was performed and the rats were randomly divided into the following four groups: OVX control group (C), treated with estradiol-17beta (E2) ‐benzoate (E; daily intake 0.086 mg/d per animal), genistein (GEN; daily intake 12.7 mg/d per animal) and equol (EQ; daily intake 4.65 mg/d per animal). At 5 weeks postoperatively (OS), the breaking test was performed on the trochanteric region of femur. Additionally, histomorphometric assessment, and trabecular and cortical bone microstructure analyses were performed. The relative gain of body weight (BW) in the EQ (24 %) group was significantly (p < 0.05) lower than in the C (33 %) and GEN (30 %) groups. After treatment for 5 weeks, the maximal load (Fmax) and yield load (yL) were higher (p < 0.05 for the weight-adapted results) in the E (188.4 N resp. 113.1 N) and EQ (177.3 N resp. 112 N) groups as compared to C (162.8 N resp. 109.1 N) and GEN (165.7 N resp. 108.8 N). In the histomorphometric tests the E- (trabecular area (Tb.Ar) = 74.93 %, trabecular nodes/mm2 (N.Nd/mm2) = 48.65) and EQ-treated (Tb.Ar = 63.13 %, N.Nd/mm2 = 43.72) animals showed significant improvement with regard to Tb.Ar and trabecular connectivity (N.Nd./mm2) in comparison to C (Tb.Ar = 46.84, N.Nd/mm2 = 31.86) and GEN (Tb.Ar = 48.22 %, N.Nd/mm2 = 34.15). There were no differences in relative cortical width (Ct.Wi) among the four groups. The treatment with EQ resulted in improved biomechanical and histomorphometric properties as compared to the treatment with GEN. Thus, of the studied substances, EQ seems to be a possible alternative to hormone replacement therapy, but further studies are needed.
- 17 September 2009
- Published by Georg Thieme Verlag KG in Planta Medica
- Vol. 76 (03) , 235-240
Changes in the Histomorphometric and Biomechanical Properties of the Proximal Femur of Ovariectomized Rat after Treatment with the Phytoestrogens Genistein and Equol
The isoflavonoids found in soy have attracted great interest as dietary phytoestrogens that might be effective for postmenopausal hormone replacement therapy. Special attention has been devoted to the hormonal effects of various isoflavonoids, like genistein (GEN) and daidzein's (DAID) potent metabolite, equol (EQ). Here we aimed to investigate the short-term effects of genistein and equol on the proximal femur of ovariectomized (OVX) rats. Forty-eight, 3-month-old female Sprague-Dawley rats were ovarectomized; after eight weeks the bilateral osteotomy and osteosynthesis (OS) of their tibiae was performed and the rats were randomly divided into the following four groups: OVX control group (C), treated with estradiol-17beta (E2) ‐benzoate (E; daily intake 0.086 mg/d per animal), genistein (GEN; daily intake 12.7 mg/d per animal) and equol (EQ; daily intake 4.65 mg/d per animal). At 5 weeks postoperatively (OS), the breaking test was performed on the trochanteric region of femur. Additionally, histomorphometric assessment, and trabecular and cortical bone microstructure analyses were performed. The relative gain of body weight (BW) in the EQ (24 %) group was significantly (p < 0.05) lower than in the C (33 %) and GEN (30 %) groups. After treatment for 5 weeks, the maximal load (Fmax) and yield load (yL) were higher (p < 0.05 for the weight-adapted results) in the E (188.4 N resp. 113.1 N) and EQ (177.3 N resp. 112 N) groups as compared to C (162.8 N resp. 109.1 N) and GEN (165.7 N resp. 108.8 N). In the histomorphometric tests the E- (trabecular area (Tb.Ar) = 74.93 %, trabecular nodes/mm2 (N.Nd/mm2) = 48.65) and EQ-treated (Tb.Ar = 63.13 %, N.Nd/mm2 = 43.72) animals showed significant improvement with regard to Tb.Ar and trabecular connectivity (N.Nd./mm2) in comparison to C (Tb.Ar = 46.84, N.Nd/mm2 = 31.86) and GEN (Tb.Ar = 48.22 %, N.Nd/mm2 = 34.15). There were no differences in relative cortical width (Ct.Wi) among the four groups. The treatment with EQ resulted in improved biomechanical and histomorphometric properties as compared to the treatment with GEN. Thus, of the studied substances, EQ seems to be a possible alternative to hormone replacement therapy, but further studies are needed.
- 4 July 2008
- Published by Springer Nature in Journal of Bone and Mineral Metabolism
- Vol. 26 (4) , 321-327
Bone development in female rats maintained with soy-free or soy-containing food as determined by computer-assisted tomography and serum bone markers
The development of bone in immature rats and in aged rats has not been thoroughly studied. Therefore, we investigated the development of bones in young, middleaged, and aged female rats. Because most rat chows contain soy proteins, including estrogenic isoflavones, as a source of protein, comparison of effects on mineral density and on areas of the cancellous and cortical parts of the metaphysis of the tibia as measured by quantitative computer tomography in animals fed with soy-free and soy-containing food was made. As surrogate parameters of bone metabolism serum, osteocalcin (OC) and the breakdown products of bone collagen—the Crosslaps—were also determined. The cancellous density increased between day 25 after birth to reach peak bone mass at 90 days of age; in 18-and 20-month-old animals, significant reduction was observed that was more profound in the animals fed with soy-free food. Serum OC and the Crosslaps were highest in 15-day-old and lowest in 9-, 18-, and 20-month-old animals. Animals fed with soy-containing food had significantly higher osteocalcin levels at day 15 and at 9 and 18 months of age. In the aged animals, intake of soy isoflavones that have an estrogenic effect appears to exert beneficial effects as these aged animals lost less cancellous bone, as indicated by their surrogate parameters of metabolism in the serum. It is concluded that exorbitantly high bone turnover is present in immature and peripubertal rats. Raising and keeping female rats under soy-free or soy-containing conditions has marked effects on several bone parameters that are of particular relevance in aged animals.
- 4 July 2008
- Published by Springer Nature in Journal of Bone and Mineral Metabolism
- Vol. 26 (4) , 321-327
Bone development in female rats maintained with soy-free or soy-containing food as determined by computer-assisted tomography and serum bone markers
The development of bone in immature rats and in aged rats has not been thoroughly studied. Therefore, we investigated the development of bones in young, middleaged, and aged female rats. Because most rat chows contain soy proteins, including estrogenic isoflavones, as a source of protein, comparison of effects on mineral density and on areas of the cancellous and cortical parts of the metaphysis of the tibia as measured by quantitative computer tomography in animals fed with soy-free and soy-containing food was made. As surrogate parameters of bone metabolism serum, osteocalcin (OC) and the breakdown products of bone collagen—the Crosslaps—were also determined. The cancellous density increased between day 25 after birth to reach peak bone mass at 90 days of age; in 18-and 20-month-old animals, significant reduction was observed that was more profound in the animals fed with soy-free food. Serum OC and the Crosslaps were highest in 15-day-old and lowest in 9-, 18-, and 20-month-old animals. Animals fed with soy-containing food had significantly higher osteocalcin levels at day 15 and at 9 and 18 months of age. In the aged animals, intake of soy isoflavones that have an estrogenic effect appears to exert beneficial effects as these aged animals lost less cancellous bone, as indicated by their surrogate parameters of metabolism in the serum. It is concluded that exorbitantly high bone turnover is present in immature and peripubertal rats. Raising and keeping female rats under soy-free or soy-containing conditions has marked effects on several bone parameters that are of particular relevance in aged animals.
- Open Access
- 21 April 2005
- Published by Oxford University Press (OUP) in Carcinogenesis
- Vol. 26 (8) , 1360-1367
Tectorigenin and other phytochemicals extracted from leopard lily Belamcanda chinensis affect new and established targets for therapies in prostate cancer
Isoflavones have been shown to exert antiproliferative effects on cancer cells by steroid receptor signaling. In this study, we demonstrate the potential of plant constituents extracted from Belamcanda chinensis as anticancer drugs, which regulate the aberrant expression of genes relevant in proliferation, invasion, immortalization and apoptosis. LNCaP cells were treated with B.chinensis extract, tectorigenin or other isoflavones and mRNA expression was quantified by using real time RT–PCR. In addition, ELISA, TRAP assays and western blots were used to measure protein expression or activity. Male nude mice ( n = 18) were injected subcutaneously with LNCaP cells and were fed with extracts from B.chinensis , and tumor development was monitored versus a control animal group ( n = 18). Tectorigenin and several other phytochemicals downregulated PDEF, PSA and IGF-1 receptor mRNA expression in vitro . Furthermore, PSA secretion and IGF-1 receptor protein expression were diminished, and hTERT mRNA expression and telomerase activity decreased after tectorigenin treatments. However, TIMP-3 mRNA was upregulated on tectorigenin treatment. Growth of subcutaneous tumors in nude mice was delayed and diminished in animals fed with extracts from B.chinensis . The downregulation of PDEF, PSA, hTERT and IGF-1 receptor gene expression by tectorigenin demonstrates the antiproliferative potential of these agents. The upregulation of TIMP-3 gene expression indicates a pro-apoptotic function of the drug and a reduction of the invasiveness of tumors. The animal experiments demonstrate that B.chinensis markedly inhibited the development of tumors in vivo . Thus, these compounds may be useful for the prevention or treatment of human prostate cancer.
- 21 April 2005
- Published by Oxford University Press (OUP) in Carcinogenesis
- Vol. 26 (8) , 1360-1367
Open AccessTectorigenin and other phytochemicals extracted from leopard lily Belamcanda chinensis affect new and established targets for therapies in prostate cancer
Isoflavones have been shown to exert antiproliferative effects on cancer cells by steroid receptor signaling. In this study, we demonstrate the potential of plant constituents extracted from Belamcanda chinensis as anticancer drugs, which regulate the aberrant expression of genes relevant in proliferation, invasion, immortalization and apoptosis. LNCaP cells were treated with B.chinensis extract, tectorigenin or other isoflavones and mRNA expression was quantified by using real time RT–PCR. In addition, ELISA, TRAP assays and western blots were used to measure protein expression or activity. Male nude mice ( n = 18) were injected subcutaneously with LNCaP cells and were fed with extracts from B.chinensis , and tumor development was monitored versus a control animal group ( n = 18). Tectorigenin and several other phytochemicals downregulated PDEF, PSA and IGF-1 receptor mRNA expression in vitro . Furthermore, PSA secretion and IGF-1 receptor protein expression were diminished, and hTERT mRNA expression and telomerase activity decreased after tectorigenin treatments. However, TIMP-3 mRNA was upregulated on tectorigenin treatment. Growth of subcutaneous tumors in nude mice was delayed and diminished in animals fed with extracts from B.chinensis . The downregulation of PDEF, PSA, hTERT and IGF-1 receptor gene expression by tectorigenin demonstrates the antiproliferative potential of these agents. The upregulation of TIMP-3 gene expression indicates a pro-apoptotic function of the drug and a reduction of the invasiveness of tumors. The animal experiments demonstrate that B.chinensis markedly inhibited the development of tumors in vivo . Thus, these compounds may be useful for the prevention or treatment of human prostate cancer.
- 14 March 2003
Phytoestrogens: endocrine disrupters or replacement for hormone replacement therapy?
This review presents findings with clear statements from the literature as well as own results of effects of soy, red clover and their isoflavones as well as of the Cimicifuga racemosa extract BNO 1055. Experimental and clinical effects on climacteric complaints, osteoprotective effects, activity in the urogenital tract, and risks concerning cardiovascular diseases and mammary and endometrial tissue will be compared, also in comparison to classical hormone preparations. The question whether soy and red clover products and/or Cimicifuga racemosa (CR) preparations are endocrine disrupters or may fulfill the criteria of the so-called phyto-SERMs will be discussed. Review of selected publications since 1980 and summary of unpublished own results of the authors. Experimental and clinical evidences suggest that soy/red clover and their isoflavones do not fulfill the criteria of an ideal SERM. They appear to have mild osteoprotective effects but do not improve climacteric complaints. Furthermore, they seem to stimulate uterine growth and mammary epithelial proliferation. In ovariectomized rats, the CR extract BNO 1055 showed many of the beneficial effects of 17beta-estradiol, including effects in the brain/hypothalamus to reduce serum LH levels, effects in the bone to prevent osteoporosis and estrogenic effects in the urinary bladder. The CR extract BNO 1055 had no uterotrophic effect. If clinical studies confirm these results, the Cimicifuga racemosa preparation BNO 1055 would appear as an ideal SERM and may therefore be an alternative to hormone replacement therapy.
- 14 March 2003
Phytoestrogens: endocrine disrupters or replacement for hormone replacement therapy?
This review presents findings with clear statements from the literature as well as own results of effects of soy, red clover and their isoflavones as well as of the Cimicifuga racemosa extract BNO 1055. Experimental and clinical effects on climacteric complaints, osteoprotective effects, activity in the urogenital tract, and risks concerning cardiovascular diseases and mammary and endometrial tissue will be compared, also in comparison to classical hormone preparations. The question whether soy and red clover products and/or Cimicifuga racemosa (CR) preparations are endocrine disrupters or may fulfill the criteria of the so-called phyto-SERMs will be discussed. Review of selected publications since 1980 and summary of unpublished own results of the authors. Experimental and clinical evidences suggest that soy/red clover and their isoflavones do not fulfill the criteria of an ideal SERM. They appear to have mild osteoprotective effects but do not improve climacteric complaints. Furthermore, they seem to stimulate uterine growth and mammary epithelial proliferation. In ovariectomized rats, the CR extract BNO 1055 showed many of the beneficial effects of 17beta-estradiol, including effects in the brain/hypothalamus to reduce serum LH levels, effects in the bone to prevent osteoporosis and estrogenic effects in the urinary bladder. The CR extract BNO 1055 had no uterotrophic effect. If clinical studies confirm these results, the Cimicifuga racemosa preparation BNO 1055 would appear as an ideal SERM and may therefore be an alternative to hormone replacement therapy.